MXPA02003952A - Derivados de imidazol como inhibidores de la fosfodieterasa vii. - Google Patents
Derivados de imidazol como inhibidores de la fosfodieterasa vii.Info
- Publication number
- MXPA02003952A MXPA02003952A MXPA02003952A MXPA02003952A MXPA02003952A MX PA02003952 A MXPA02003952 A MX PA02003952A MX PA02003952 A MXPA02003952 A MX PA02003952A MX PA02003952 A MXPA02003952 A MX PA02003952A MX PA02003952 A MXPA02003952 A MX PA02003952A
- Authority
- MX
- Mexico
- Prior art keywords
- imidazole derivatives
- phosphodiesterase vii
- vii inhibitors
- relates
- hal
- Prior art date
Links
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 239000002606 phosphodiesterase VII inhibitor Substances 0.000 title abstract 2
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 abstract 2
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
Abstract
Derivados de imidazol de la formula I (ver formula) donde: R1 es H, A, bencilo, indan-5-ilo, 1,2,3,4-tetrahidro-naftalen-5ilo, dibenzotien-2ilo o fenilo no sustituido o mono-, di- o trisustituido por Hal, A, A-CO-NH, benciloxi, alcoxi, COOH o COOA, R2 es H o A X es O o S, Hal es F, C1, Br o I A es alquilo con entre 1 y 6 atomos de carbono y las sales y/o solvatos fisiologicamente aceptables de los mismos, como inhibidores de la fosfodiesterasa VII, y el uso de los mismos para producir un medicamento.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19950647A DE19950647A1 (de) | 1999-10-21 | 1999-10-21 | Imidazolderivate als Phosphodiesterase VII-Hemmer |
| PCT/EP2000/009926 WO2001029049A2 (de) | 1999-10-21 | 2000-10-10 | Imidazolderivate als phosphodiesterase vii-hemmer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02003952A true MXPA02003952A (es) | 2004-09-06 |
Family
ID=7926352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02003952A MXPA02003952A (es) | 1999-10-21 | 2000-10-10 | Derivados de imidazol como inhibidores de la fosfodieterasa vii. |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1222193B1 (es) |
| JP (1) | JP2003512381A (es) |
| KR (1) | KR20020060201A (es) |
| CN (1) | CN1382146A (es) |
| AR (1) | AR026198A1 (es) |
| AT (1) | ATE247121T1 (es) |
| AU (1) | AU780788B2 (es) |
| BR (1) | BR0014922A (es) |
| CA (1) | CA2388314C (es) |
| CZ (1) | CZ293751B6 (es) |
| DE (2) | DE19950647A1 (es) |
| DK (1) | DK1222193T3 (es) |
| ES (1) | ES2200957T3 (es) |
| HU (1) | HUP0203139A3 (es) |
| MX (1) | MXPA02003952A (es) |
| NO (1) | NO20021846D0 (es) |
| PL (1) | PL355020A1 (es) |
| PT (1) | PT1222193E (es) |
| RU (1) | RU2259199C2 (es) |
| SK (1) | SK4922002A3 (es) |
| WO (1) | WO2001029049A2 (es) |
| ZA (1) | ZA200203995B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2294189T3 (es) * | 2001-12-13 | 2008-04-01 | Asubio Pharma Co., Ltd. | Derivados de pirazolopirimidinona que tienen accion inhibidora de pde7. |
| DE10163991A1 (de) * | 2001-12-24 | 2003-07-03 | Merck Patent Gmbh | Pyrrolo-pyrimidine |
| JP2006219374A (ja) | 2003-06-13 | 2006-08-24 | Daiichi Asubio Pharma Co Ltd | Ｐｄｅ７阻害作用を有するイミダゾトリアジノン誘導体 |
| JP2006219373A (ja) | 2003-06-13 | 2006-08-24 | Daiichi Asubio Pharma Co Ltd | Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体 |
| JP4810426B2 (ja) | 2004-07-01 | 2011-11-09 | 第一三共株式会社 | Ｐｄｅ７阻害作用を有するチエノピラゾール誘導体 |
| AU2008230710B2 (en) | 2007-03-27 | 2014-04-10 | Omeros Corporation | The use of PDE7 inhibitors for the treatment of movement disorders |
| US8637528B2 (en) | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
| US9220715B2 (en) | 2010-11-08 | 2015-12-29 | Omeros Corporation | Treatment of addiction and impulse-control disorders using PDE7 inhibitors |
| KR20220047894A (ko) | 2010-11-08 | 2022-04-19 | 오메로스 코포레이션 | Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료 |
| KR20250048344A (ko) | 2022-08-18 | 2025-04-08 | 미토디큐어 게엠베하 | 만성 피로, 탈진 및/또는 운동 불내성과 연관된 질환의 치료 및 예방을 위한 포스포디에스테라제-7 억제 활성을 갖는 치료제의 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4305954A (en) * | 1981-02-11 | 1981-12-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 3,4-dihydro(or 1,4-dihydro)-2-[(substituted)thio]-[1]benzopyrano[3,4-d]imidazoles and their corresponding sulfoxides and sulfones |
| EP0714395B1 (en) * | 1993-08-19 | 1999-03-31 | Janssen Pharmaceutica N.V. | Vasoconstrictive substituted dihydropyranopyridines |
| DE19632423A1 (de) * | 1996-08-12 | 1998-02-19 | Merck Patent Gmbh | Thienopyrimidine |
| TW591030B (en) * | 1997-03-10 | 2004-06-11 | Janssen Pharmaceutica Nv | Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles |
| JP2003526608A (ja) * | 1998-10-15 | 2003-09-09 | バイオイメージ エイ／エス | 再分布及び／又は標的化での干渉によって得られる特異的治療の介入 |
| AU4589800A (en) * | 1999-05-05 | 2000-11-21 | Darwin Discovery Limited | 9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7inhibitors |
-
1999
- 1999-10-21 DE DE19950647A patent/DE19950647A1/de not_active Withdrawn
-
2000
- 2000-10-10 KR KR1020027004903A patent/KR20020060201A/ko not_active Withdrawn
- 2000-10-10 AU AU11356/01A patent/AU780788B2/en not_active Ceased
- 2000-10-10 WO PCT/EP2000/009926 patent/WO2001029049A2/de not_active Ceased
- 2000-10-10 DK DK00972714T patent/DK1222193T3/da active
- 2000-10-10 RU RU2002111413/15A patent/RU2259199C2/ru not_active IP Right Cessation
- 2000-10-10 ES ES00972714T patent/ES2200957T3/es not_active Expired - Lifetime
- 2000-10-10 AT AT00972714T patent/ATE247121T1/de not_active IP Right Cessation
- 2000-10-10 CN CN00814402A patent/CN1382146A/zh active Pending
- 2000-10-10 PT PT00972714T patent/PT1222193E/pt unknown
- 2000-10-10 CA CA002388314A patent/CA2388314C/en not_active Expired - Fee Related
- 2000-10-10 EP EP00972714A patent/EP1222193B1/de not_active Expired - Lifetime
- 2000-10-10 DE DE50003309T patent/DE50003309D1/de not_active Expired - Lifetime
- 2000-10-10 BR BR0014922-5A patent/BR0014922A/pt not_active IP Right Cessation
- 2000-10-10 JP JP2001531847A patent/JP2003512381A/ja active Pending
- 2000-10-10 CZ CZ20021251A patent/CZ293751B6/cs not_active IP Right Cessation
- 2000-10-10 SK SK492-2002A patent/SK4922002A3/sk unknown
- 2000-10-10 PL PL00355020A patent/PL355020A1/xx unknown
- 2000-10-10 HU HU0203139A patent/HUP0203139A3/hu unknown
- 2000-10-10 MX MXPA02003952A patent/MXPA02003952A/es unknown
- 2000-10-20 AR ARP000105542A patent/AR026198A1/es unknown
-
2002
- 2002-04-19 NO NO20021846A patent/NO20021846D0/no not_active Application Discontinuation
- 2002-05-20 ZA ZA200203995A patent/ZA200203995B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2200957T3 (es) | 2004-03-16 |
| NO20021846L (no) | 2002-04-19 |
| AR026198A1 (es) | 2003-01-29 |
| WO2001029049A2 (de) | 2001-04-26 |
| RU2259199C2 (ru) | 2005-08-27 |
| KR20020060201A (ko) | 2002-07-16 |
| SK4922002A3 (en) | 2002-09-10 |
| CA2388314A1 (en) | 2001-04-26 |
| HUP0203139A3 (en) | 2004-12-28 |
| CZ293751B6 (cs) | 2004-07-14 |
| DK1222193T3 (da) | 2003-12-01 |
| AU1135601A (en) | 2001-04-30 |
| DE19950647A1 (de) | 2001-04-26 |
| PL355020A1 (en) | 2004-03-22 |
| WO2001029049A3 (de) | 2001-11-01 |
| DE50003309D1 (de) | 2003-09-18 |
| EP1222193A2 (de) | 2002-07-17 |
| ZA200203995B (en) | 2003-10-29 |
| BR0014922A (pt) | 2002-06-11 |
| CZ20021251A3 (cs) | 2002-07-17 |
| CA2388314C (en) | 2009-06-16 |
| CN1382146A (zh) | 2002-11-27 |
| HUP0203139A2 (hu) | 2003-01-28 |
| NO20021846D0 (no) | 2002-04-19 |
| JP2003512381A (ja) | 2003-04-02 |
| AU780788B2 (en) | 2005-04-14 |
| EP1222193B1 (de) | 2003-08-13 |
| ATE247121T1 (de) | 2003-08-15 |
| PT1222193E (pt) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU91417I2 (fr) | "Maraviroc, optionnellement sous forme d'un sel pharmaceutiquement acceptable CELSENTRI" | |
| BE2018C008I2 (es) | ||
| BG106585A (en) | Kinase inhibitors as therapeutic agents | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| MY116915A (en) | Substituted indazole analogs | |
| NZ514873A (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | |
| CA2113229A1 (en) | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof | |
| MXPA02004448A (es) | Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii. | |
| YU11299A (sh) | Derivati indazola | |
| AP0102304A0 (en) | Substituted indazole derivatives and related compounds. | |
| BG105666A (en) | Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-beta-cyclodextrin or 2-hydroxypropyl-beta-cyclodextrin and method for forming the complex | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| DK0928788T3 (da) | Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler | |
| MXPA02004440A (es) | Derivados de pirrol como inhibidores de la fosfodiesterasa vii. | |
| ZA953981B (en) | New azolidinediones as antihyperglycemic agents | |
| ATE271045T1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| EP0640080A1 (en) | SUBSTITUTED INDOLE AND AZAINDOLE AS ANGIOTENSIN II ANTAGONISTS. | |
| MXPA02003952A (es) | Derivados de imidazol como inhibidores de la fosfodieterasa vii. | |
| WO2001036425A3 (de) | Imidazolverbindungen als phosphodiesterase vii-hemmer | |
| PL340658A1 (en) | Derivatives of biphenylamidine | |
| IL160082A0 (en) | Quinoline derivatives and use thereof as antitumor agents | |
| MXPA03004023A (es) | Compuestos quimicos. | |
| ZA200500436B (en) | 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors | |
| ES2193047T3 (es) | (3,4 dihydro-2h-benzo(1,4) oxazinilmetil)(3-(1h-indol-3-il)-alquil)-aminas. | |
| NZ508280A (en) | 2- or 3-cyanoiminoquinoxaline derivatives useful as glutamate receptor antagonists |